APL-2
APL2-GA-305
Phase 3 small_molecule active
Quick answer
APL-2 for Geographic Atrophy Secondary to Age-Related Macular Degeneration is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active